£425.00

It has never been this cheap. We have no record of a lower price.

£425 today · cheaper than every other day in the last 3 months

Anti-Migraine Drugs in Europe Outlook 2016-2021 Report

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days · 90 data points

Historical
Generating forecast…
£425.00 £403.75 £412.25 £420.75 £429.25 £437.75 £446.25 12 August 2026 03 September 2026 25 September 2026 17 October 2026 09 November 2026
View at Amazon ↗

Price data checked 1 day ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 90 days • 1 price levels

Days at Price
90 days 0 23 45 68 90 £425 Days at Price

Price Analysis

Most common price: £425 (90 days, 100.0%)

Price range: £425 - £425

Price levels: 1 different prices over 90 days

Description

This econometric study provides a detailed outlook for the anti-migraine drug market in Europe from 2016 to 2021. Through the use of econometric models that project fundamental economic dynamics, the report establishes latent demand estimates for various countries. Readers can access potential industry earnings (P.I.E.) in millions of U.S. dollars for each reported year. The study includes comparative benchmarks such as the percent share each country holds within the region and across the globe. These metrics allow for a quick assessment of individual country performance relative to others. This technical resource is designed for professionals needing data-driven insights into the economic landscape of the European anti-migraine pharmaceutical sector.

Key Features

Provides latent demand estimates and potential industry earnings (P.I.E.) in millions of U.S. dollars for each reported year.

Includes comparative benchmarks for each country to gauge performance against regional and global market shares.

Uses econometric models to project fundamental economic dynamics within and across specific countries.

Covers the specific outlook for the anti-migraine drug market in Europe for the period of 2016-2021.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
21 May 2015
Listed Since
01 October 2015

Similar Products You Might Like

Anti-Migraine Drug Outlook in Asia 2016-2021 Study
99% match

Anti-Migraine Drug Outlook in Asia 2016-2021 Study

£425.00 06 Nov 2026
Anti-Migraine Drug Outlook Latin America 2016-2021 Study
99% match

Anti-Migraine Drug Outlook Latin America 2016-2021 Study

£425.00 07 Nov 2026
Anti-Migraine Drug Outlook North America & Caribbean Study
99% match

Anti-Migraine Drug Outlook North America & Caribbean Study

£425.00 05 Nov 2026
Anti-Migraine Drug Outlook in Oceana 2016-2021 Study
99% match

Anti-Migraine Drug Outlook in Oceana 2016-2021 Study

£425.00 26 Sep 2026
Anti-Migraine Drug Outlook in Middle East (2011-2016)
99% match

Anti-Migraine Drug Outlook in Middle East (2011-2016)

£325.00 09 Nov 2026
The 2021-2026 World Outlook for Anti-Migraine Drugs
99% match

The 2021-2026 World Outlook for Anti-Migraine Drugs

£795.00 09 Nov 2026
US Anti-Migraine Drug Market Outlook 2023-2028 Study
99% match

US Anti-Migraine Drug Market Outlook 2023-2028 Study

£520.00 07 Nov 2026
US Anti-Migraine Drug Market Outlook 2016-2021 Study
99% match

US Anti-Migraine Drug Market Outlook 2016-2021 Study

£595.00 06 Nov 2026
2025-2030 World Outlook for Anti-Migraine Drugs Study
99% match

2025-2030 World Outlook for Anti-Migraine Drugs Study

Price unavailable
Anti-Migraine Drug Outlook in Greater China 2016-2021
99% match

Anti-Migraine Drug Outlook in Greater China 2016-2021

£595.00 25 Aug 2026
Anti-Migraine Drugs in India Outlook 2023-2028 Study
98% match

Anti-Migraine Drugs in India Outlook 2023-2028 Study

£515.00 09 Nov 2026
The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs
98% match

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

£795.00 07 Nov 2026
US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study
98% match

US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study

£490.00 04 Sep 2026
Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)
97% match

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

OmniScriptum

£70.00 30 Sep 2026
Migraine and Headache Disorders: Global Perspective - SDG3
97% match

Migraine and Headache Disorders: Global Perspective - SDG3

Springer

£95.74 25 Sep 2026
Management of Migraine Pain: Emerging Opportunities and Challenges
97% match

Management of Migraine Pain: Emerging Opportunities and Challenges

Springer

£162.90 02 Oct 2026
Interventional Management of Migraines and Headache Disorders Book
97% match

Interventional Management of Migraines and Headache Disorders Book

Elsevier

£119.49 02 Oct 2026
Migraine
96% match

Migraine

IntechOpen

£118.98 12 Sep 2026
Migraine, Words and Fiction
96% match

Migraine, Words and Fiction

Cambridge Scholars Publishing

£67.99 23 Sep 2026
The Biochemistry of Migraine
96% match

The Biochemistry of Migraine

Springer

£158.11 19 Sep 2026
Comorbid Conditions in the Treatment of Headache
96% match

Comorbid Conditions in the Treatment of Headache

CRC Press

£75.11 11 Sep 2026
Clinical Scales for Headache Disorders
96% match

Clinical Scales for Headache Disorders

Springer

£95.74 19 Sep 2026
Neuroimaging of Headache Disorders
96% match

Neuroimaging of Headache Disorders

Springer

£101.05 18 Sep 2026
Update on Emerging Treatments for Migraine (Volume 255) (Progress in Brain Research, Volume 255)
96% match

Update on Emerging Treatments for Migraine (Volume 255) (Progress in Brain Research, Volume 255)

Elsevier

£193.39 25 Sep 2026